Cluster Seizures: Cluster seizures that last from hours to days and typically begin between the ages of three months and three years. Seizures are often difficult to control and progress negatively.
Developmental delay: Most patients with PCDH19 epilepsy experience delays and eventually intellectual disability after seizures begin.
PCDH19 epilepsy primarily affects females
PCDH19 epilepsy is suspected based on symptoms but is confirmed through genetic testing that identifies a mutation in the PCDH19 gene.
Currently there is no cure for PCDH19 epilepsy. Patients are treated for their symptoms, not for the underlying cause of the disease. Seizure control is the primary goal for patients with PCDH19 epilepsy. There are currently companies investigating treatments for PCDH19 epilepsy and researchers analyzing patient data to better understand the condition so a cure may be found.
The average person with a rare disease sees 7.3 specialists over a span of 5-7 years before receiving an accurate diagnosis. AmbitCare Ambassadors provide free services including listening to understand your challenges, guiding you on potential next steps, and recommending resources.
Have additional questions? Contact an AmbitCare Ambassador by phone at 1-877-584-8995 or by email at info@ambitinc.com today.
Our hours of operation are Monday-Friday, 9-5pm ET. An AmbitCare Ambassador will typically respond within 1-2 business days.
© 2021 Ambit Care. All Rights Reserved.
Disclaimer
Please note that AmbitCare provides this information for the benefit of the rare disease community. AmbitCare is not a medical provider nor a health care facility. AmbitCare can neither diagnose any disease or disorder nor endorse or recommend any specific medical treatments. Individuals must rely on the personal and individualized medical advice of their qualified health care professionals before seeking any information related to their particular diagnosis, cure, or treatment of a condition or disorder.
